Prices delayed by at least 15 minutes | Print
Synairgen PLC (SNG)
ORD 1PThis share can be held in a Dealing accountISALifetime ISAJISASIPPand can be used with Dividend reinvestment
Company profile
Synairgen PLC is a United Kingdom-based respiratory drug discovery and development company. The company is engaged in the drug discovery and development of therapies for respiratory diseases, particularly in the areas, including severe asthma, kidney fibrosis, cardiac fibrosis, chronic obstructive pulmonary disease, and idiopathic pulmonary fibrosis. The company's Programmes include SNG001, SG016, SG018, and others.
Address
Mailpoint 810, Level F, South Block
Southampton Gen Hospital, Tremona Road
Southampton
GBR
SO16 6YD
Telephone
+44 2380512800
Forecast key dates
Name | Key Date |
---|---|
Synairgen PLC Second Quarter Earnings Results for 2024 | 2024-09-20T00:00:00 |
Synairgen PLC Annual General Meeting for 2024 | 2024-06-28T10:00:00 |
Synairgen PLC Annual Report for 2023 | 2024-05-22T00:00:00 |
Synairgen PLC Fourth Quarter Earnings Results for 2023 | 2024-05-03T00:00:00 |
Previous key dates
Name | Key Date |
---|---|
Synairgen PLC Second Quarter Earnings Results for 2023 | 2023-09-21T00:00:00 |
Synairgen PLC Annual General Meeting for 2023 | 2023-06-29T10:00:00 |
Synairgen PLC Annual Report for 2022 | 2023-05-22T00:00:00 |
Synairgen PLC Fourth Quarter Earnings Results for 2022 | 2023-04-27T00:00:00 |
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2024 AJ Bell. All rights reserved.